Trials / Recruiting
RecruitingNCT06481176
Blood Changes After Exercise in Restless Legs Syndrome
Proteomic Response to Exercise in Adults With Restless Legs Syndrome
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn how exercise changes molecules in the blood in people with restless legs syndrome (RLS) to better understand the cause(s) of RLS. The main questions the investigators aim to answer are: How does long-term exercise change proteins in the blood? How does a single exercise session change proteins in the blood? The investigators will compare long-term exercise to no exercise to see if the changes in proteins are specific to exercise. Participants will complete an exercise test and provide blood samples before and after the exercise test. Participants will be randomized (like the flip of a coin) in to either the exercise or no-exercise group for 12 weeks and then complete the exercise test and blood samples again at the end.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | 12-Week RLS Exercise Program | Participants will complete 12 weeks of an evidence-based exercise program that has been used for people with RLS, designed for people with RLS, and was informed by exercise guidelines outlined by the American College of Sports Medicine (ACSM) and the American Heart Association, and Center for Disease Control. The program includes three sessions per week for 12 weeks including: * cardiovascular exercise (e.g., walking/jogging, bicycling) for 30 minutes/day on at least 3 days/week at a moderate-to-vigorous intensity * strength training on 2 non-consecutive days/week targeting major muscle groups for approximately 30 minutes * Stretching all major muscle groups on three or more days per week |
Timeline
- Start date
- 2024-10-21
- Primary completion
- 2026-08-01
- Completion
- 2026-12-01
- First posted
- 2024-07-01
- Last updated
- 2024-11-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06481176. Inclusion in this directory is not an endorsement.